Skip to content

Clinical trials

Completed Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Status: Completed Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20111
20121
20142
20152
20163
20171
20182
20193
20204
20224
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Children's Hospital of Zhejiang University School of Medicine3
Beijing Boren Hospital2
Institute of Hematology & Blood Diseases Hospital, China2
Nanfang Hospital, Southern Medical University2
Novartis Pharmaceuticals2
Pfizer2
Shengjing Hospital2
Amgen1
Betta Pharmaceuticals Co., Ltd.1
Chinese Academy of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma30
Leukemia4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Philadelphia Chromosome2
Recurrence2
Anorectal Malformations1
Constipation1
Fecal Incontinence1
Leukemia, Biphenotypic, Acute1
Leukemia, Lymphocytic, Chronic, B-Cell1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.